Phreesia(PHR)
icon
搜索文档
Wall Street Analysts Think Phreesia (PHR) Could Surge 27.77%: Read This Before Placing a Bet
ZACKS· 2024-07-19 22:56
Shares of Phreesia (PHR) have gained 13.2% over the past four weeks to close the last trading session at $22.65, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $28.94 indicates a potential upside of 27.8%.The average comprises 16 short-term price targets ranging from a low of $23 to a high of $34, with a standard deviation of $2.57. While the lowest estimate indicates an increa ...
Phreesia (PHR) Upgraded to Strong Buy: Here's What You Should Know
ZACKS· 2024-07-13 01:01
Phreesia (PHR) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate.Since a changing earnings ...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Phreesia, Inc. – PHR
GlobeNewswire News Room· 2024-07-13 00:45
NEW YORK, July 12, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Phreesia, Inc. (“Phreesia” or the “Company”) (NYSE: PHR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Phreesia and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class action] On May 30, 2024, Phr ...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Phreesia, Inc. - PHR
GlobeNewswire News Room· 2024-06-06 05:04
NEW YORK, June 05, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Phreesia, Inc. (“Phreesia” or the “Company”) (NYSE: PHR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Phreesia and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class action] On May 30, 2024, Phr ...
Here's Why Phreesia (PHR) is Poised for a Turnaround After Losing -18.25% in 4 Weeks
ZACKS· 2024-06-04 22:36
A downtrend has been apparent in Phreesia (PHR) lately with too much selling pressure. The stock has declined 18.3% over the past four weeks. However, given the fact that it is now in oversold territory and Wall Street analysts are majorly in agreement about the company's ability to report better earnings than they predicted earlier, the stock could be due for a turnaround. Here is How to Spot Oversold Stocks We use Relative Strength Index (RSI), one of the most commonly used technical indicators, for spott ...
Phreesia(PHR) - 2025 Q1 - Quarterly Report
2024-06-01 04:03
公司财务表现 - 2024年4月30日,公司总收入增长21%,达到1.012亿美元,相比于2023年同期的8380万美元[126] - 2024年4月30日,公司净亏损为1970万美元,相比于2023年同期的3750万美元净亏损[126] - 2024年4月30日,调整后的EBITDA为410万美元,相比于2023年同期的负1380万美元[126] - 2024年4月30日,经营活动中的净现金流为负700万美元,相比于2023年同期的负1370万美元[126] - 2024年4月30日,自由现金流为负620万美元,相比于2023年同期的负1970万美元[126] - 2024年4月30日,现金及现金等价物为7950万美元,相比于2024年1月31日减少800万美元[126] 客户数据 - 平均每个医疗服务客户(AHSCs)数量为4065,2024年4月30日[155] - 每个医疗服务客户的医疗服务收入为18155美元,2024年4月30日,相比于去年同期的18779美元,下降了3%[156] - 每个医疗服务客户的总收入为24900美元,2024年4月30日,相比于去年同期的25338美元,下降了2%[158] 收入来源 - 订阅和相关服务收入增长23%,达到4674.2万美元[176] - 患者支付处理费收入增长12%,达到2706万美元[176] - 网络解决方案收入增长26%,达到2741.5万美元[176] 成本和费用 - 除折旧和摊销外的成本增长5%,达到1572.3万美元[180] - 支付处理费用增长14%,达到1829.7万美元[182] - 销售和营销费用减少14%,达到3201.1万美元[185] - 研发费用增长9%,达到2888.1万美元[188] - 行政和管理费用减少4%,达到1905.2万美元[191] 其他财务信息 - 2024年4月30日,其他费用减少至31,000美元,同比下降26%[194] - 利息收入减少至239,000美元,同比下降67%[195] - 所得税减少至510,000美元,同比增加67%[196] - 调整后的EBITDA为4,093,000美元,较上年同期改善[200] - 自由现金流为-6,167,000美元,较上年同期改善[202] 资金情况和融资 - 公司相信现有的现金和现金等价物足以满足未来12个月的资金需求[203] - 公司已终止与Silicon Valley Bank的融资协议,并与Capital One签订了新的信贷协议[205] - 公司认为现有的现金和现金等价物足以满足未来12个月的资金需求[209] - 公司在2023年6月签订了融资协议,截至2024年4月30日,尚有2.8百万美元的本金和利息未偿还[210] 外汇风险 - 公司的运营和现金流受外汇汇率波动影响,特别是加拿大元和印度卢比的变化可能对未来产生不利影响[228] - 三个月截至2024年4月30日,大约89%的支出以美元计价[228] - 外汇损失主要来自货币账户余额的重新计量,2024年4月30日三个月的外汇损失为0.1百万美元[229]
Phreesia(PHR) - 2025 Q1 - Earnings Call Transcript
2024-05-31 07:22
财务数据和关键指标变化 - 第一季度收入同比增长21%,达到1.012亿美元 [16] - 调整后EBITDA首次在3年内转正,达到410万美元 [16] - 医疗服务客户数较上一季度增加103家,客户平均收入为24,900美元 [16] - 第一季度收入受到约170万美元的负面影响,主要是由于与一家结算中心客户的关系加速终止 [17][18] 各条业务线数据和关键指标变化 - 支付处理业务收入受到约170万美元的负面影响,是由于与一家结算中心客户的关系加速终止 [17][18] 各个市场数据和关键指标变化 - 公司表示医疗服务市场仍然良好,尽管存在一些挑战,但团队在持续赢得新客户并增加市场份额 [41][42] 公司战略和发展方向及行业竞争 - 公司正在加大对网络解决方案的投资,认为这将是推动客户总收入增长的最大驱动力 [44][45][53][55][56] - 公司推出了MediFind预约请求功能,初步反馈良好,预计将成为公司未来获取新客户的重要渠道 [48][49][50][54][55] 管理层对经营环境和未来前景的评论 - 公司表示已经做好充分准备应对网络安全挑战,并在过去几年持续加大相关投资 [26][27][28][29] - 公司认为当前的经营环境和市场需求良好,有信心在下半年开始产生自由现金流 [20][21][22] - 公司更加注重短期内提升盈利能力,并在与股东的交流中得到了支持 [22] 其他重要信息 - 公司更新了2025财年的收入和调整后EBITDA指引,收入下调800万美元,调整后EBITDA上调600万美元至2600万美元 [19][36][37] - 公司现金储备为8000万美元,无借款,财务状况良好 [20][21] 问答环节重要的提问和回答 问题1 **Anne Samuel 提问** 询问公司在网络安全方面的投资计划,以及Ascension遭受攻击对公司的影响 [25][26][27][28][29] **Balaji Gandhi 和 Chaim Indig 回答** 公司一直在加大网络安全投资,并已经聘请了相关专家,这部分开支已经体现在管理费用中 [26][27][28][29] 问题2 **Jared Haase 提问** 询问公司为何决定终止与结算中心客户的合作,以及是否存在其他与Change Healthcare相关的风险 [31][32][33][34] **Balaji Gandhi 回答** 这是一个特殊情况,客户希望整合到单一供应商,而公司出于多方面考虑无法满足,因此双方协商终止合作,时间被Change Healthcare的网络攻击事件所加速 [33][34] 问题3 **Jailendra Singh 提问** 询问调整后EBITDA大幅上调的原因,以及公司是否更加注重盈利能力 [36][37][38] **Balaji Gandhi 回答** 公司一直在朝这个方向努力,现在更加积极主动,考虑到资本成本等因素,但仍然会平衡增长和盈利的需求 [37][38]
Compared to Estimates, Phreesia (PHR) Q1 Earnings: A Look at Key Metrics
ZACKS· 2024-05-31 06:31
For the quarter ended April 2024, Phreesia (PHR) reported revenue of $101.22 million, up 20.7% over the same period last year. EPS came in at -$0.35, compared to -$0.70 in the year-ago quarter. The reported revenue represents a surprise of +0.20% over the Zacks Consensus Estimate of $101.01 million. With the consensus EPS estimate being -$0.51, the EPS surprise was +31.37%. While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street ...
Phreesia (PHR) Reports Q1 Loss, Tops Revenue Estimates
ZACKS· 2024-05-31 06:16
Phreesia (PHR) came out with a quarterly loss of $0.35 per share versus the Zacks Consensus Estimate of a loss of $0.51. This compares to loss of $0.70 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 31.37%. A quarter ago, it was expected that this developer of health care software would post a loss of $0.58 per share when it actually produced a loss of $0.56, delivering a surprise of 3.45%. Over the last four quarters, the c ...
Phreesia(PHR) - 2025 Q1 - Quarterly Results
2024-05-31 04:02
Exhibit 99.1 Phreesia Announces First Quarter Fiscal 2025 Results ALL-REMOTE COMPANY/WILMINGTON, D.E., May 30, 2024 – Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the fiscal first quarter ended April 30, 2024. "I am tremendously proud of our team’s commitment to our growth and profitability1 objectives." said CEO and Co- Founder Chaim Indig. Please visit the Phreesia investor relations website at ir.phreesia.com to view the Company's Q1 Fiscal Year 2025 Stak ...